Skip to main content
logo
Ionis Pharmaceuticals, Inc. (LON:0JDI)
London flag London · Delayed Price · Currency is GBP · Price in USD
61.11
-2.61 (-4.09%)
At close: Sep 15, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Commercial Licensing and Other Royalty
22.60M
Log In
Log In
Log In
Log In
Upgrade
Commercial Licensing and Other Royalty Growth
44.48%
Log In
Log In
Log In
Log In
Upgrade
Total R&D
-
Log In
Log In
Log In
Log In
Upgrade
Total R&D Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
38.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-99.94%
Log In
Log In
Log In
Log In
Upgrade
SPINRAZA Royalties
216.10M
Log In
Log In
Log In
Log In
Upgrade
SPINRAZA Royalties Growth
-0.53%
Log In
Log In
Log In
Log In
Upgrade
TEGSEDI and WAYLIVRA
34.20M
Log In
Log In
Log In
Log In
Upgrade
TEGSEDI and WAYLIVRA Growth
9.28%
Log In
Log In
Log In
Log In
Upgrade
Amortization from Upfront Payments
131.40M
Log In
Log In
Log In
Log In
Upgrade
Amortization from Upfront Payments Growth
-
Log In
Log In
Log In
Log In
Upgrade
Milestone Payments
106.40M
Log In
Log In
Log In
Log In
Upgrade
Milestone Payments Growth
-
Log In
Log In
Log In
Log In
Upgrade
R&D License Fees
71.30M
Log In
Log In
Log In
Log In
Upgrade
R&D License Fees Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other R&D Services
23.50M
Log In
Log In
Log In
Log In
Upgrade
Other R&D Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Eplontersen Joint Development
79.40M
Log In
Log In
Log In
Log In
Upgrade
Eplontersen Joint Development Growth
-23.76%
Log In
Log In
Log In
Log In
Upgrade
WAINUA Royalties
20.20M
Log In
Log In
Log In
Log In
Upgrade